Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Sotylize...
Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing its second New Drug Application (NDA). ...
Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Nymalize™...
Arbor Pharmaceuticals announced today that it has filed its first New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA). The...
Arbor Pharmaceuticals, a specialty pharmaceutical company based in Atlanta, GA, announced today the completion of a $34.8 million financing. This...
Arbor Pharmaceuticals, a specialty pharmaceutical company based in Atlanta, GA, announced today that Laurence J. Downey, MD has joined the company as ...
Arbor Pharmaceuticals, a specialty pharmaceutical company focused on pediatric medicine, announced today that an investment group led by Jason Wild...
Arbor Pharmaceuticals ("Arbor"), a specialty pharmaceutical company focused exclusively on pediatric medicine, announced today that the company has...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.